Clinical Trial Update: Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer

View source ↗

Summary

Clinical trial results update on the effectiveness of Hexaminolevulinate (Hexvix) for diagnosing and treating non-muscle invasive bladder cancer, with completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Hexvix (hexaminolevulinate hydrochloride)

Snippet

Sponsor: GE Healthcare | Conditions: Bladder Cancer | Status: COMPLETED | Results posted: 2014-08-25